Life-threatening allergic bronchopulomnary aspergillosis treated with methylprednisolone and anti-IgE monoclonal antibody.
Thomas
Matthew F
MF
Department of Respiratory Paediatrics, Royal Victoria Infirmary, Newcastle Upon Tyne, UK. matthomas@doctors.org.uk
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000150:complications* / Q000188:drug therapy; D002648:Child; D003550:Cystic Fibrosis / Q000150:complications*; D006801:Humans; D006967:Hypersensitivity; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; C026408:anti-IgE antibodies; D008775:Methylprednisolone